Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells

2014/04/13 by Yifan Zhu, Svetlana Karakhanova, Xiaolun Huang +3 · 16 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Biology #CD24 #CD44 #Cancer #Cancer Cells and Metastasis #Cancer research #Cancer stem cell #Cancer, Hypoxia, and Metabolism #Cell #Cytokine #Immune cells in cancer #Immunology #In vivo #Interferon #Medicine #Metastasis #Pancreatic cancer #Population #Stem cell #Stem cell marker

paper · doi:10.1016/j.yexcr.2014.03.020

openalex publication_date 2014/04/13 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications. [europepmc]
• Interplay between inflammatory tumor microenvironment and cancer stem cells. [europepmc]
• Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling. [europepmc]
• A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs. [europepmc]
• The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway. [europepmc]
• Immune evasion by cancer stem cells. [europepmc]
• The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation. [europepmc]
• Stem Cells and Cancer Stem Cells: The Jekyll and Hyde Scenario and Their Implications in Stem Cell Therapy. [europepmc]
• Low Levels of TRIM28-Interacting KRAB-ZNF Genes Associate with Cancer Stemness and Predict Poor Prognosis of Kidney Renal Clear Cell Carcinoma Patients. [europepmc]
• Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response. [europepmc]
• Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B. [europepmc]
• Cancer cells escape the immune system by increasing stemness through epigenetic reprogramming. [europepmc]
• Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis. [europepmc]
• Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective. [europepmc]
• Circulating tumor cells: from new biological insights to clinical practice. [europepmc]
• The Emerging Role of Peroxisome Proliferator-Activated Receptors in Cancer Stemness. [europepmc]